当前位置:首页 - 行情中心 - 上海医药(601607) - 财务分析

上海医药

(601607)

  

流通市值:506.24亿  总市值:673.07亿
流通股本:27.89亿   总股本:37.08亿

上海医药(601607)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润49.95亿元,每股收益1.20元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益8885790.46万元,未分配利润3991494.47万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产23806705.61万元,负债14920915.15万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入141,592,782,502.7970,762,515,910.94275,250,934,889.66209,628,733,748.35
营业总成本137,611,880,810.1968,666,635,360.52267,676,306,689.98203,433,368,171.18
其他经营收益
营业利润6,833,619,624.552,146,390,114.158,140,712,946.176,668,766,941.12
利润总额6,820,820,702.732,152,717,007.538,020,006,543.746,644,377,262.89
净利润4,994,784,030.291,640,193,471.65,870,011,314.885,023,298,063.88
每股收益
其他综合收益19,680,758.31-3,441,851.94-62,617,948.59-26,585,406.09
综合收益总额5,014,464,788.61,636,751,619.665,807,393,366.294,996,712,657.79
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计184,456,754,035.33177,311,702,074.79171,823,107,421.97173,787,729,817.04
非流动资产:
非流动资产合计53,610,302,036.0448,560,189,615.0249,386,322,726.249,953,615,974.66
资产总计238,067,056,071.37225,871,891,689.81221,209,430,148.17223,741,345,791.7
流动负债:
流动负债合计140,131,022,109.65130,813,134,867.82126,038,386,279.1129,532,122,995.82
非流动负债:
非流动负债合计9,078,129,398.079,757,787,539.4211,428,680,14811,051,710,878.25
负债合计149,209,151,507.72140,570,922,407.24137,467,066,427.1140,583,833,874.07
所有者权益(或股东权益):
归属于母公司股东权益合计75,095,652,523.3373,010,725,504.8671,675,619,971.9770,865,778,972.83
股东权益合计88,857,904,563.6585,300,969,282.5783,742,363,721.0783,157,511,917.63
负债和股东权益合计238,067,056,071.37225,871,891,689.81221,209,430,148.17223,741,345,791.7
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计151,090,834,889.9372,342,373,807.62304,650,625,623.94219,416,492,667.27
经营活动现金流出小计150,101,577,901.0474,546,689,410.83298,823,367,892.61216,633,528,211.01
经营活动产生的现金流量净额989,256,988.89-2,204,315,603.215,827,257,731.332,782,964,456.26
投资活动产生的现金流量:
投资活动现金流入小计37,691,184,962.9416,458,582,841.150,433,234,630.1519,354,120,323.73
投资活动现金流出小计38,931,450,587.817,431,520,246.1150,017,254,930.4618,996,138,579.94
投资活动产生的现金流量净额-1,240,265,624.86-972,937,405.01415,979,699.69357,981,743.79
筹资活动产生的现金流量:
筹资活动现金流入小计41,955,523,827.7823,252,698,353.1874,149,022,397.9755,183,838,786.63
筹资活动现金流出小计38,202,146,690.0219,388,489,487.1976,012,952,776.6355,047,062,826.06
筹资活动产生的现金流量净额3,753,377,137.763,864,208,865.99-1,863,930,378.66136,775,960.57
汇率变动对现金及现金等价物的影响-13,772,678.984,038,703.532,156,741.31-22,872,683.73
现金及现金等价物净增加额3,488,595,822.81690,994,561.34,381,463,793.673,254,849,476.89
期末现金及现金等价物余额35,369,868,617.6832,572,267,356.1731,881,272,794.8730,754,658,478.09
补充资料:
现金及现金等价物的净增加额3,488,595,822.81-4,381,463,793.67-
最新报告期:2025-09-05
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中邮证券龙永茂1.541.491.642025-09-05
中信建投刘若飞,贺菊颖1.691.331.452025-09-05
中国银河程培,闫晓松1.781.491.642025-08-31
中金公司夏璐,张琎,朱言音1.341.45--2025-08-31
华福证券何展聪,陈铁林1.681.351.492025-08-29
TOP↑